chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got the vaccine but then she got covid.; She got the vaccine but then she got covid.; This is a spontaneous report from a contactable consumer or other non hcp. A 21-years-old female patient received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on May2021 as DOSE 2, SINGLE, dose 1 via an unspecified route of administration, administered in Arm on May2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was none. There were no concomitant medications. On an unspecified date in 2021 patient experienced breakthrough infection, she got the vaccine but then she got covid and sick on 03Aug2021. The patient underwent lab tests and procedures which included sars-cov-2 test: covid-19 on 03Aug2021. The outcome for all events was unknown.  Information about lo/batch number has been requested.
Shot taken on Wednesday (Oct 15). 4 days later started having congestion, coughing and sore throat. Very aching body. Loss of appetite. Lung area very tender and painful. (Temperature).
13 days after receiving the second covid vaccination, Patient's heat rhythm went from his normal sinus bradycardia  into atrial fibrillation.  I took him to ER where he was diagnosed with atrial fibrillation, given 2 attempts to cardiovert the rhythm which were unsuccessful, and put on a Diltiazem drip, to which he eventually converted back to his normal sinus rhythm after several hours.  We are firm believers in getting vaccinated against Covid, and are not 100% sure what caused the arrhythmia.  Patient is extremely healthy and works our regularly, and it is just strange and suspect, that the event happened after receiving the vaccination.
Patient reports an itchy rash developing on her arms and knees the night she received her vaccine (at around 8:30 PM). She stated that the symptoms are being managed with Benadryl and hydrocortisone and that she has had no symptoms on her face/mouth/throat.
Received vaccine 10/12/17 began with redness, mild swelling, heat, mild pain and itching on 10/13/17. Has taken ibuprofen and BENADRYL. Sx still present today 10/18/17 but client able to work and do usual activities.
Light headed and dizzy beginning approximately 10 minutes post vaccination. Swelling of tongue and itching in throat beginning approximately 20 minutes post vaccination. At this point patient notified observation nurse.  Assessed by EMTs and nurse practitioner on site. Received injection of 25 mg of Benadryl. Began having relief of symptoms within 3 minutes. No  Transported to hospital for observation. Received oxygen during transport.  ER gave famotidine and loratadine via pills at 3:44 pm. Observation for approximately 70 minutes. At this point it had been approximately 4 hours since injection. BP and oxygen levels good. No itching. Released and returned home.  Patient was cold and tired, which is typical for them when receiving a Benadryl injection. Slept for approximately 14 hours.  Currently tired and achy, which is again typical for them after receiving a Benadryl injection.
The adverse symptoms happened in my 3'rd vaccination (IE the booster) which I received yesterday Jan 28, 2022. I received the dose at 1:10pm and began feeling nausea at about 6pm. At around 9pm, I got up and thought I was going to get ill and almost did. I was sweating, dizzy, and flushed. I also had chills, body aches and a massive headache. At 3:30am, I woke up with a massive headache and have been extremely exhausted since yesterday. I did not have these side effects with either my first or second doses.
Diarrhea; Arm pain of injection; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and VACCINATION SITE PAIN (Arm pain of injection) in a 94-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Constipation and Colonoscopy.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (Arm pain of injection). On 26-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). On 15-Mar-2021, VACCINATION SITE PAIN (Arm pain of injection) had resolved. At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Neurological side effect of sensory neuropathy in the arms and legs; pins and needle sensation that goes and comes; Based on information received on 12-Oct-2020, the report previously considered as non-valid became valid: [events peripheral sensory neuropathy and paraesthesia added].  Initial information regarding an unsolicited non-valid non-serious case was received from a consumer (patient) via agency (Reference number- 00313675) and transmitted to Sanofi on 13-Oct-2020.  This case involves a 61-years-old female patient who experienced neurological side effect of sensory neuropathy in the arms and legs (peripheral sensory neuropathy) and pins and needle sensation that goes and comes (paraesthesia), while she received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical treatment included CIPRO [CIPROFLOXACIN] and had same neurological side effects that lasted 8 to 9 months.  The patient's medical history, past vaccinations, family history were not provided. The patient did not receive any concomitant medications.  On 30-Sep-2020, the patient received a 0.5 mL dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (Suspension for injection, lot number and expiry date not reported) via an unknown route in an unknown administration site for prophylactic vaccination.  On 02-Oct-2020, the patient developed neurological side effect of sensory neuropathy in the arms and legs (peripheral sensory neuropathy) and pins and needle sensation that goes and comes (paraesthesia) two days following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the patient had not recovered from the events.  There will be no information on the batch number for this case.  Follow up information regarding an unsolicited valid non-serious case was received from a consumer (patient) via agency (Reference number- 00311975) and transmitted to Sanofi on 12-Oct-2020 (as per source).  Case became valid, events (peripheral sensory neuropathy and paraesthesia) along with as reported added, historical drug, suspect vaccine updated to FLUZONE QUADRIVALENT, vaccination date and dosing details, event onset date added and event outcome updated.
Headache,  nausea,  dizziness,  weakness,  fatigue for 24 hours. bed rest and hydrated until able to eat and stay up on second day
This case was reported by a nurse via sales rep and described the occurrence of swelling in a 62-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced swelling and erythema. On an unknown date, the outcome of the swelling and erythema were unknown. It was unknown if the reporter considered the swelling and erythema to be related to SHINGRIX. Additional details were provided as follows: The nurse practitioner and office manager reported this case. The patient experienced significant swelling and redness. The reporter agreed for follow up contact.
Shingles Vaccination -Redness, Soreness, itching with in 24 hours.
Stomach pain, Loose stools, Neck pain, Wrist and arm pain, Extreme fatigue, Bad headache, Eye pain, Chills.
patient received a Moderna vaccine that was open since the 8Jul2022; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received a Moderna vaccine that was open since the 8Jul2022) in a 45-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 059A22A and 059A22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 08-Jun-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 11-Jul-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received a Moderna vaccine that was open since the 8Jul2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received a Moderna vaccine that was open since the 8Jul2022) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-May-2022, SARS-CoV-2 test: Positive.     For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter. The patient received a Moderna vaccine that was open since 08-Jul-2022, on the 11-Jul-2022. Treatment information was not provided.
Individual became lightheaded and diaphoretic a few minutes after receiving injection. He stated ?this happens to me when I get shots?.  Vitals stable, no difficulty breathing or loss of consciousness.
Rash on entire side of my body, itchy, very red. Woke up with it morning after my vaccine, lasted for a week.
No adverse etfects reported; patient received improperly stored dose of MMR II; This spontaneous report was received from a nurse and refers to a 12-month-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 17-JUL-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # R024905, expiration date 30-AUG-2020, albumin status rHA (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the highest temperature excursion of above 47 degrees Fahrenheit (54 degrees Fahrenheit) for 17 hours and 15 minutes on 12-JUL-2019. Data logger was involved. There were no previous excursions reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1911USA004662:
Client accidentally administered DTaP too early. Parents notified of mistake and that injection will not be considered valid and will need repeating later. No adverse reaction at time of report.
Information has been received on 24-MAY-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 19-APR-2017, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster also known as shingles and other complications. Later in 2017, the patient was treated at a community clinic for a blistering vesicular outbreak, which was diagnosed as severe shingles. The patient has been prescribed acyclovir for management of her painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
flushness in face; Swelling of throat; tingling in mouth; This is a spontaneous report from a contactable consumer. A 33-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EW0150), via an unspecified route of administration in left arm on 31Mar2021 17:00 (at the age of 33-years-old) as dose 1, single for COVID-19 immunization. Medical history included allergy to Sulfa-containing medications. Concomitant medication included multivitamins [vitamins nos]. Prior to vaccination, the patient was not diagnosed with COVID-19 and did not receive any vaccines within four weeks prior. The patient experienced flushness in face, swelling of throat and tingling in mouth on 31Mar2021 18:15. The events resulted in emergency room/department or urgent care visit. Since the vaccination, patient has not been tested for COVID-19. No treatment was received for the event. Outcome of events was resolving.  No follow-up attempts are possible. No further information is expected.
Sore throat and "white crap" all over in the back of her throat; Spots on the tongue; "white crap" all over in the back of her throat; sore arm; she does not feel well; the lymph nodes in her neck is swollen; feeling really down; extremely tired; extremely weak; This is a spontaneous report from a contactable consumer. A 33-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: not reported), dose 1 via an unspecified route of administration on 24Jul2021 as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced sore arm on Jul2021, sore throat and "white crap" all over in the back of her throat on 31Jul2021, spots on the tongue on 31Jul2021, in 2021 patient was not feeling well, the lymph nodes in her neck was swollen, feeling really down, extremely tired, and extremely weak. The patient reported having sore arm for a couple of days which was fine now and 2 days ago, she woke up with sore throat and "white crap" all over in the back of her throat as well as white patches and spots on the tongue and did not manifest until a week later. She reported she was not running a fever but a sore throat and does not feel like a normal cold since there was no congestion of the nose. Caller described it as a "not regular sore throat" and that she does not feel well and the lymph nodes in her neck was swollen. She also mentioned feeling really down and extremely tired and not feeling well. She stated that she was fine and then 6-7 days later, she woke up with a freaking sore throat and have had it for a couple of days now. She also got swabbed and tested negative for strep throat in which the they told her that it was "something viral." She never had white crap in the back of her throat and all she knows is that she feels like "crap." She was thinking that it might be from the vaccine. The patient was unsure if it was related with the vaccine and was wondering if it is possible to manifest side effects 6-7 days after and how long they last. She wanted to know if there are any reports of people that have gotten sick and not getting better after receiving the vaccine. Seriousness of the events was provided as unspecified. Investigation Assessment was not provided. The patient has been extremely weak. She has a sore throat, feels really weird and off. This is not like a normal cold. She did not feel good and is most concerned about that. The patient underwent lab tests and procedures which included culture throat: negative on Jul2021. She also got swabbed and tested negative for strep throat. The clinical outcome of the events extremely weak, extremely tired, feeling really down, the lymph nodes in her neck is swollen, she does not feel well, was unknown. The clinical outcome of the event sore arm was resolved on an unspecified date in Jul2021 and clinical outcome of all other events was not resolved.  The lot number for the vaccine was not provided and will be requested during follow up.
This spontaneous report as received from a healthcare worker refers to a 4 year old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 19-JUN-2015, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (lot # K010211, expiry date 17-JAN-2016; dose and route were not reported). No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
I received my vaccine at 9:58 AM, on 2/2 and at 7 PM I started to feel feverish and chills. I had a 103 fever for the night. Fever slowly reduced for the next day and by 7PM the following night I no longer had a fever.
Per patient:  Woke up the next morning and my left arm (arm that I got the injection in), left gluteus muscle, entire left leg, were all really burning.  Rapidly worsening pain in left arm, all muscles in shoulder, clavicle, scapula, and socket where humerus meets the scapula.  Near total loss of use of the left arm for 2.5 months.  Unable to lift hand higher than waist (lifting forward with elbow at my side and forearm almost parallel to the ground), and unable to lift my arm sideways away from my body at all for the same amount of time.  Currently (2/16/21) able to very slowly lift the arm past waist, although quite painful.  Unable to lift anything with any weight, open jars, basically just do everyday things with left arm.  Even dressing, putting on a coat, sleeping are extremely painful.  Everything still burns a little bit.  As of 2/17/21 patient is reporting pain in right arm on the bone between bicep, tricep and deltoid that woke him up in the middle of the night.
itchy; developed a bump at the injection site; arm started getting red; arm was sore, red, and itchy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore, red, and itchy), ERYTHEMA (arm started getting red), PRURITUS (itchy) and VACCINATION SITE PAPULE (developed a bump at the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was sore, red, and itchy). On 09-Feb-2021, the patient experienced ERYTHEMA (arm started getting red) and VACCINATION SITE PAPULE (developed a bump at the injection site). On an unknown date, the patient experienced PRURITUS (itchy). On 05-Feb-2021, PAIN IN EXTREMITY (arm was sore, red, and itchy) had resolved. At the time of the report, ERYTHEMA (arm started getting red), PRURITUS (itchy) and VACCINATION SITE PAPULE (developed a bump at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment details included None.
Pt complained of itching and warm feeling no sob or dizziness. Was evaluated by EMS, they recommended giving liquid benadryl 25mg. Pt vitals sign BP 132/78 R 20 P 78 o2 97%. PT reported feeling better after receiving the benadryl waited an additional 30 mins before leaving. Refused any other treatment.
WHEN I AWOKE ON THE 8TH DAY AFTER BEING VACCINATED, AT 07:00 MY LEFT ARM ITCHED AT THE POINT OF INJECTION.  THIS GOT WORSE AS THE DAY PROGRESSED.  AROUND NOON  AN AREA FROM THE INJECTION SITE TO THE CREASE IN THE ELBOW HAD TURNED RED AND SWOLLEN.   IT ALSO TURNED FLABBY, LIKE MY BICEP WAS A WATER BALOON.  THE REDNESS, SWELLING AND ITCHING  WORSENED UNTIL BEDTIME AT 11:00.  AT 06:00 THE FOLLOWING MORNING ALL 3 SYMPTOMS SEEMED TO BE RECEEDING. THIS WAS CONFIRMED BY MY WIFE.  BY EVENING, EXCEPT FOR AN ANNOYING ITCH, ALL APPAERED NORMAL.
PATIENT REC'D 1/2 HEP B VACCINE MIXED WITH 1/2 ADULT TDAP VACCINE
Morning sugar is up to 135-140 without eating any sugar; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (Morning sugar is up to 135-140 without eating any sugar) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes (Normally, 110 in the morning before vaccine administration.).   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERGLYCAEMIA (Morning sugar is up to 135-140 without eating any sugar). At the time of the report, HYPERGLYCAEMIA (Morning sugar is up to 135-140 without eating any sugar) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 135-140 (High) Morning sugar is up to 135-140 without eating any sugar..         Concomitant product use was not provided by the reporter. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 67-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Aug2023 as dose 6 (booster), single (Lot number: GK0928) at the age of 67 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 4 (booster), single (Batch/Lot number: unknown) and as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Sick sinus syndrome" (unspecified if ongoing); "Hypothyroidism" (unspecified if ongoing); "HTN" (unspecified if ongoing); "Sulfa allergy" (unspecified if ongoing), notes: Known allergies: Sulfa allergy; "Gluten sensitivity" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "recovered" (Oct2023) and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid treatment from 27Sep2023 to 02Oct2023. Clinical Course: Symptoms had fully resolved as of about 3 days into first Paxlovid treatment did not have access to retest at that time.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product to the reported event Drug ineffective and COVID 19 cannot be ruled out.    ,Linked Report(s) : US-PFIZER INC-202300328852 same patient, different drug and event (Paxlovid case);
Given 5-11 yr vaccine instead of 12 yr and older vaccine No adverse events.  Parent contacted when error was discovered
Patient became fully vaccinated on 6/18/21 and is currently admitted to hospital with COVID19 as of 10/1/21, hypoxic, requiring oxygen